Post by icemandios on Aug 3, 2017 14:54:51 GMT
This content is copyright protected
However, if you would like to share the information in this article, you may use the headline, summary and link below:
Ocular cuts jobs post FDA rejection
By Flora Southey, 03-Aug-2017
Ocular Therapeutix has announced it is laying off 19% of its workforce in order to cut operating expenses.
www.in-pharmatechnologist.com/Regulatory-Safety/Ocular-cuts-jobs-post-FDA-rejection
However, if you would like to share the information in this article, you may use the headline, summary and link below:
Ocular cuts jobs post FDA rejection
By Flora Southey, 03-Aug-2017
Ocular Therapeutix has announced it is laying off 19% of its workforce in order to cut operating expenses.
www.in-pharmatechnologist.com/Regulatory-Safety/Ocular-cuts-jobs-post-FDA-rejection